Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041432) titled 'Cold Ischemia Time Loses Prognostic Significance After Controlled Oxygenated Rewarming in Liver Transplantation' on Sept. 1.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Universitatsklinikum Essen
Condition:
Liver transplantation for advanced liver disease
Intervention:
Group 1: Retrospective observational cohort of 64 adult patients who underwent primary liver transplantation at our center between November 2022 and April 2025 following ex situ controlled oxygenated rewarming (COR) of the donor liver. No study-related interv...